09606 映恩生物－Ｂ
公司背景| 業務概覽| 企業架構| 基本數據| 財務比率| 損益表| 財務狀況表| 現金流量表| 派息紀錄| 盈利預測| 股權變動| 股票賣空
公司資料 - 股權變動
股權披露
配股集資
公司回購
日期 股東名稱 披露原因 買入／賣出涉及
的股份數目		 每股平均價 持有權益的
股份數目		 佔已發行
股本(%)
28/10/2025Morgan Stanley1306(L)155,800(L)4,956,353(L)
3,109,716(S)
0(P)		5.62
3.53
0.00
27/10/2025Morgan Stanley1305(L)67,400(L)5,112,567(L)
3,269,662(S)
0(P)		5.80
3.71
0.00
24/10/2025Morgan Stanley1305(L)863,900(L)6,532,577(L)
3,110,458(S)
0(P)		7.42
3.53
0.00
24/10/2025Morgan Stanley1213(L)-1,420,010(L)5,112,567(L)
3,269,662(S)
0(P)		5.80
3.71
0.00
23/10/2025Morgan Stanley1305(L)34,700(L)6,706,789(L)
3,175,467(S)
0(P)		7.61
3.60
0.00
22/10/2025Morgan Stanley1306(L)126,500(L)6,668,978(L)
3,086,279(S)
0(P)		7.57
3.50
0.00
21/10/2025朱忠远1313(L)
14015(S)		2,599,800(L)
+2,599,800(S)		16,026,123(L)
2,599,800(S)		18.20
2.95
21/10/2025Morgan Stanley1013(L)+4,525,234(L)6,668,978(L)
3,086,279(S)
0(P)		7.57
3.50
0.00
21/10/2025DualityBio Ltd.1313(L)
14015(S)		2,599,800(L)
+2,599,800(S)		6,500,000(L)
2,599,800(S)		7.38
2.95
17/10/2025LAV Corporate VI GP Opportunities, Ltd.1201(L)-1,631,500(L)HKD 277.550(L)3,779,400(L)4.29
17/10/2025LAV Asset Management (Hong Kong) Limited1201(L)-5,030,300(L)HKD 277.550(L)11,652,921(L)13.24
17/10/2025施毅1201(L)-5,030,300(L)HKD 277.550(L)11,652,921(L)13.24
17/10/2025LAV GP VI, L.P.1201(L)-3,398,800(L)HKD 277.550(L)7,873,521(L)8.94
17/10/2025LAV Corporate VI GP, Ltd.1201(L)-3,398,800(L)HKD 277.550(L)7,873,521(L)8.94
17/10/2025LAV GP VI Opportunities, L.P.1201(L)-1,631,500(L)HKD 277.550(L)3,779,400(L)4.29
17/10/2025LAV Fund VI, L.P.1201(L)-3,398,800(L)HKD 277.550(L)7,873,521(L)8.94
17/10/2025LAV Fund VI Opportunities, L.P.1201(L)-1,631,500(L)HKD 277.550(L)3,779,400(L)4.29
17/10/2025Morgan Stanley1704(L)-5,142,988(L)2,019,634(L)
503,858(S)
0(P)		2.29
0.57
0.00
16/10/2025Morgan Stanley1312(L)34,300(L)7,068,843(L)
443,864(S)
0(P)		8.02
0.50
0.00
16/10/2025King Star Med LP1201(L)-670,000(L)HKD 311.240(L)5,739,554(L)6.52
15/10/2025Morgan Stanley1013(L)+6,358,687(L)7,068,843(L)
443,864(S)
0(P)		8.02
0.50
0.00
09/05/2025施毅1213(L)16,683,221(L)16,683,221(L)18.95
09/05/2025朱忠远1312(S)-2,599,800(S)16,026,123(L)
0(S)		18.20
0.00
09/05/2025LAV Fund VI, L.P.1213(L)11,272,321(L)11,272,321(L)12.80
09/05/2025LAV Corporate VI GP, Ltd.1213(L)11,272,321(L)11,272,321(L)12.80
09/05/2025LAV GP VI, L.P.1213(L)11,272,321(L)11,272,321(L)12.80
09/05/2025DualityBio Ltd.1312(S)-2,599,800(S)6,500,000(L)
0(S)		7.38
0.00
09/05/2025LAV Asset Management (Hong Kong) Limited1213(L)16,683,221(L)16,683,221(L)18.95
15/04/2025DualityBio Ltd.1701(L)
1313(S)		6,500,000(L)
+2,599,800(S)		6,500,000(L)
2,599,800(S)		7.61
3.04
15/04/2025LAV Corporate VI GP Opportunities, Ltd.1701(L)+5,410,900(L)5,410,900(L)6.33
15/04/2025LAV Fund VI, L.P.1701(L)+11,272,321(L)11,272,321(L)13.19
15/04/2025LAV GP VI, L.P.1701(L)+11,272,321(L)11,272,321(L)13.19
15/04/2025LAV Asset Management (Hong Kong) Limited1701(L)+16,683,221(L)16,683,221(L)19.52
15/04/2025LAV Fund VI Opportunities, L.P.1701(L)+5,410,900(L)5,410,900(L)6.33
15/04/2025张韶壬1701(L)592,500(L)592,500(L)0.69
15/04/2025司文1701(L)1,367,959(L)1,367,959(L)1.60
15/04/2025LAV Corporate VI GP, Ltd.1701(L)+11,272,321(L)11,272,321(L)13.19
15/04/2025LAV GP VI Opportunities, L.P.1701(L)+5,410,900(L)5,410,900(L)6.33
15/04/2025朱忠远1701(L)
1313(S)		16,026,123(L)
+2,599,800(S)		16,026,123(L)
2,599,800(S)		18.76
3.04
15/04/2025施毅1701(L)+16,683,221(L)16,683,221(L)19.52
 1  
備註： (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
  (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.